ORIGINAL RESEARCH
Accepted on 10 Feb 2025
Multi-omics analysis reveals Jianpi formula-derived bioactive peptide-YG-22 potentially inhibited colorectal cancer via regulating epigenetic reprogram and signal pathway regulation
doi 10.3389/fgene.2025.1560172